MedPath

Testing the effect of drug ketamine (anaesthetic agent) in reducing pain following surgery and opioid consumption by giving through erector spinae block.

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/064029
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients undergoing Modified Radical Mastectomy

2. ASA 1-3

3. 18 – 70 years of age

Exclusion Criteria

1. Inability to communicate

2. Contraindications of Nerve Block

3. Chronic opioid or analgesic use

4. Allergic to study medications

5. BMI more than 35

6. Patients with CAD

7. Patients with preexisting dementia, h/o seizure disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess postoperative pain by NRS score <br/ ><br>Timepoint: At 1hour, 2hours, 4hours, 8hours, 12hours, 24hours
Secondary Outcome Measures
NameTimeMethod
Time of activation of PCA pump <br/ ><br> Cumulative consumption of fentanyl administered through PCA Pump <br/ ><br> Acute postoperative neuropathic pain as assessed by DN4 Questionnaire <br/ ><br> Use of rescue analgesics <br/ ><br> Incidence of opioid induced adverse effects <br/ ><br> Post operative nausea & vomiting <br/ ><br> Pruritis <br/ ><br> Respiratory depression <br/ ><br> Length of hospital stayTimepoint: At 24hours, 48hours, 72hours
© Copyright 2025. All Rights Reserved by MedPath